352 related articles for article (PubMed ID: 32502659)
1. Potential role of statins in COVID-19.
Lee KCH; Sewa DW; Phua GC
Int J Infect Dis; 2020 Jul; 96():615-617. PubMed ID: 32502659
[TBL] [Abstract][Full Text] [Related]
2. Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia.
Vuorio A; Kovanen PT
J Clin Lipidol; 2020; 14(5):617-618. PubMed ID: 32653497
[No Abstract] [Full Text] [Related]
3. Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung.
Dastan F; Abedini A; Shahabi S; Kiani A; Saffaei A; Zare A
Iran J Allergy Asthma Immunol; 2020 May; 19(S1):10-12. PubMed ID: 32534505
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of Effect of Statins in Patients with COVID-19.
Kow CS; Hasan SS
Am J Cardiol; 2020 Nov; 134():153-155. PubMed ID: 32891399
[No Abstract] [Full Text] [Related]
5. Are statins safe in patients with COVID-19?
Karalis DG
J Clin Lipidol; 2020; 14(4):396-397. PubMed ID: 32682805
[No Abstract] [Full Text] [Related]
6. Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2.
Skayem C; Ayoub N
Am J Med Sci; 2020 Sep; 360(3):300. PubMed ID: 32631576
[No Abstract] [Full Text] [Related]
7. In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19.
Zhang XJ; Qin JJ; Cheng X; Shen L; Zhao YC; Yuan Y; Lei F; Chen MM; Yang H; Bai L; Song X; Lin L; Xia M; Zhou F; Zhou J; She ZG; Zhu L; Ma X; Xu Q; Ye P; Chen G; Liu L; Mao W; Yan Y; Xiao B; Lu Z; Peng G; Liu M; Yang J; Yang L; Zhang C; Lu H; Xia X; Wang D; Liao X; Wei X; Zhang BH; Zhang X; Yang J; Zhao GN; Zhang P; Liu PP; Loomba R; Ji YX; Xia J; Wang Y; Cai J; Guo J; Li H
Cell Metab; 2020 Aug; 32(2):176-187.e4. PubMed ID: 32592657
[TBL] [Abstract][Full Text] [Related]
8. Statins in coronavirus outbreak: It's time for experimental and clinical studies.
Bifulco M; Gazzerro P
Pharmacol Res; 2020 Jun; 156():104803. PubMed ID: 32289478
[No Abstract] [Full Text] [Related]
9. COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.
Siniorakis E; Arvanitakis S; Nikolopoulos I; Elkouris M
mBio; 2020 May; 11(3):. PubMed ID: 32444383
[No Abstract] [Full Text] [Related]
10. Tocilizumab in COVID-19: Beware the risk of intestinal perforation.
Vikse J; Henry BM
Int J Antimicrob Agents; 2020 Jul; 56(1):106009. PubMed ID: 32389721
[No Abstract] [Full Text] [Related]
11. Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?
Eroğlu I; Çelik Eroğlu B; Uyaroğlu OA; Sain Güven G
Anatol J Cardiol; 2020 Jul; 24(1):19-20. PubMed ID: 32628145
[No Abstract] [Full Text] [Related]
12. COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?
Şen S; Üresin AY
Turk Kardiyol Dern Ars; 2020 Oct; 48(7):631-634. PubMed ID: 33034579
[No Abstract] [Full Text] [Related]
13. Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
Costiniuk CT; Jenabian MA
Cytokine Growth Factor Rev; 2020 Jun; 53():63-65. PubMed ID: 32467020
[No Abstract] [Full Text] [Related]
14. The Multiple Effects of SGLT2 Inhibitors Suggest Potential Benefit in COVID-19 Patients.
Soni S; Dyck JRB
Can J Cardiol; 2020 Oct; 36(10):1691.e3. PubMed ID: 32717278
[No Abstract] [Full Text] [Related]
15. The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19.
Tsioufis C; Dimitriadis K; Tousoulis D
Hellenic J Cardiol; 2020; 61(1):31-33. PubMed ID: 32450334
[No Abstract] [Full Text] [Related]
16. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening.
Zhao X; Jiang Y; Zhao Y; Xi H; Liu C; Qu F; Feng X
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1209-1220. PubMed ID: 32328850
[TBL] [Abstract][Full Text] [Related]
17. Is targeting Akt a viable option to treat advanced-stage COVID-19 patients?
Somanath PR
Am J Physiol Lung Cell Mol Physiol; 2020 Jul; 319(1):L45-L47. PubMed ID: 32519895
[No Abstract] [Full Text] [Related]
18. Covid-19: the renin-angiotensin system imbalance hypothesis.
Lanza K; Perez LG; Costa LB; Cordeiro TM; Palmeira VA; Ribeiro VT; Simões E Silva AC
Clin Sci (Lond); 2020 Jun; 134(11):1259-1264. PubMed ID: 32507883
[TBL] [Abstract][Full Text] [Related]
19. PI3Kδ Inhibition as a Potential Therapeutic Target in COVID-19.
Palma G; Pasqua T; Silvestri G; Rocca C; Gualtieri P; Barbieri A; De Bartolo A; De Lorenzo A; Angelone T; Avolio E; Botti G
Front Immunol; 2020; 11():2094. PubMed ID: 32973818
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know.
Dhawan R; Gundry RL; Brett-Major DM; Mahr C; Thiele GM; Lindsey ML; Anderson DR
J Mol Cell Cardiol; 2020 Jul; 144():12-14. PubMed ID: 32339565
[No Abstract] [Full Text] [Related]
[Next] [New Search]
